Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,663 stories, page 66 of 812

Advanced search

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Whan In Pharmaceutical Co., Ltd. Estimates – KRX:016580

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

VIVOZON PHARMACEUTICAL CO., LTD. Estimates – KRX:082800

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Zeria Pharmaceutical Co Ltd - Notice Concerning Acquisition Of Equity Interests Of Haupt Pharma Wulfling GmbH (Making It A Sub-Subsidiary) By A Consolidated Subsidiary

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Tibet Rhodiola Pharmaceutical Holding Co. Class A Estimates – SSE:600211

TradingViewOriginal source

🇪🇸Oct 26Researchcnic.esTier 2 · Direct publisher

Genome Biology: Una nueva herramienta desarrollada en el CNIC facilita la integración de datos para descubrir mecanismos biológicos implicados en las enfermedades

CNIC Spain CardiovascularOriginal source

🇪🇸Oct 26Researchcnic.esTier 2 · Direct publisher

David Sancho recibe el XXII Premio Ciencias de la Salud Fundación Caja Rural Granada

CNIC Spain CardiovascularOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Haisco Pharmaceutical Group Co. Ltd. Class A Estimates – SZSE:002653

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. Class A Estimates – SSE:688336

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Hangzhou Biotest Biotech Co., Ltd. Class A Estimates – SSE:688767

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. Class A Estimates – SSE:603896

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

China Resources Jiangzhong Pharmaceutical Co., Ltd. Class A Estimates – SSE:600750

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Lilly advances amylin-based obesity combo to phase 3, tests tolerability amid Korea race - CHOSUNBIZ

ChosunbizOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Zhongzhi Pharmaceutical Holdings Limited Estimates – HKEX:3737

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Shenzhen YHLO Biotech Co. Ltd. Class A Estimates – SSE:688575

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

BLACK BIRD BIOTECH INC Estimates – OTC:BBBT

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

fda approved weight loss drug for 2022

BusinessWorld OnlineOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

JIANMIN PHARMACEUTICAL GROUP CO LTD. Class A Estimates – SSE:600976

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

eli lilly weight loss drug in trials

emyOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Cathay Biotech, Inc. Class A Estimates – SSE:688065

TradingViewOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

fda approved weight loss drugs 2015

BusinessWorld OnlineOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

health news today fda approval weight loss drug

emyOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Weekend - China warns of countermeasures as US Treasury widens tech investment curbs to biotech

investingLiveOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

new fda weight loss drug 2023

www.polskieradio.plOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

new fda drug approved for weight loss

BusinessWorld OnlineOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

fda proposes removing key weight-loss drug ingredients from compounding list

BusinessWorld OnlineOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

fda concerns unapproved glp 1 drugs weight loss 2026

BusinessWorld OnlineOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

fda proposes restrictions on bulk compounding of popular weight-loss drugs

ΕΜΥOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Takeda to seek Japan approval for gastric cancer drug next year

ReutersOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

fda concerns unapproved glp-1 drugs weight loss official

ΕΜΥOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Stock Looks Fully Priced Today

Yahoo FinanceOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Eppendorf and BioLabs expand collaboration to support biotech innovation in Munich

Select ScienceOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

new fda approved weight loss drug 2024

ΕΜΥOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

best weight loss drops fda approved

BusinessWorld OnlineOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

fda proposes limiting mass compounding of major weight loss drugs

ΕΜΥOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Low-dose prednisolone eases long-COVID symptoms modestly, but B vitamins fail in phase 3 trial

Bioengineer.orgOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Divarasib Improves Survival vs Sotorasib or Adagrasib in KRAS G12C+ NSCLC

CancerNetworkOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

fda approved weight loss drugs 2026 latest

www.polskieradio.plOriginal source

🇮🇹Oct 26Researchpoliclinico.mi.itTier 2 · Direct publisher

Policlinico di Milano, grande partecipazione all’Open Day del nuovo Padiglione Sforza

Policlinico di MilanoOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

Bhopal Food Safety Alert: FDA Raids Sweet Shops, Collects Mawa And Laddoo Samples; Warns Against Aluminium

Free Press JournalOriginal source

🌍Oct 26discoverynews.google.comTier 3 · Aggregated media

It’s Time to Build a More Scalable, Connected CRO

PharmTech.comOriginal source

🇺🇸Oct 25Industrybiomarin.comTier 1 · Company source

Edoardo Makes Space for Ambitious Goals, Anchored in Family and Passion

BioMarin PharmaceuticalOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 Study Conducted by Akeso in China

Business WireOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

LES annual meeting; Apple v OpenAI discovery; EU countries SEP regulation push; Beijing biotech export controls; quarterly DTSA filing data; plus much more

IAM MediaOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

miracle fda approved weight loss drug newsweek

emyOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

miracle weight loss drug fda 2022

emyOriginal source

🇨🇭Oct 25Industryroche.comTier 1 · Company source

Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer

Roche NewsroomOriginal source

🌍Oct 25discoverynews.google.comTier 2 · Trade media

‘Infinite potential’: Akeso CEO looks for more ivonescimab combos amid AstraZeneca investment, new phase 3 win

Fierce PharmaOriginal source

🌍Oct 25discoverynews.google.comTier 2 · Trade media

ESMO: AstraZeneca exec insists phase 3 ADC data ‘robust’ enough for regulators despite PFS miss

Fierce BiotechOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

Forget Biotech's Binary Bets: This Dividend Stock Collects Royalties on Blockbusters Instead

The Motley FoolOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

new fda weight loss drug 2022

BusinessWorld OnlineOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

weight loss drug fda 2022

BusinessWorld OnlineOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

Forget Biotech's Binary Bets: This Dividend Stock Collects Royalties on Blockbusters Instead

AOL.comOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

Is Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap On Phase III Sac TMT Survival Data?

Yahoo FinanceOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

Cover Story : "Engineering the future of Pharmaceutical Excellences"

Microbioz IndiaOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

Why This Hair Restoration Biotech's Shares Are Soaring

The Motley FoolOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

DOD Biotech Public Co., Ltd.(Alien Mkt) Estimates – SET:DOD.F

TradingViewOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

fda concerns unapproved glp 1 drugs weight loss summary

emyOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

Bristol Myers Squibb’s cancer drug cuts risk of progression or death by 59% in Phase 3 breast cancer trial

Indian Pharma PostOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

newest fda approved weight loss drug

emyOriginal source

🌍Oct 25discoverynews.google.comTier 3 · Aggregated media

fda proposes banning large-scale compounding of popular weight-loss drugs

emyOriginal source